Advertisement

U.S. Cancer Morbidity and Mortality Trends

  • K.G. Manton
  • Igor Akushevich
  • Julia Kravchenko
Part of the Statistics for Biology and Health book series (SBH)

Introduction: Cancer Mortality and Morbidity Registration

The vital records and statistics system in the United States began at the local level in the eighteenth century, and then progressed to the state level in the nineteenth century. In the 1930s, the national vital statistics system was developed (U.S. Vital Statistics System, 1950). Population-based cancer mortality data in the U.S. began to be collected at the beginning of the twentieth century. From 1930 to 1998, mortality data included information on race, gender, year, and age at death, which were published annually in Vital Statistics of the United States (U.S. Department of Health, Education, and Welfare, 1950–1959; Federal Security Agency, 1945–1949; U.S. Department of Commerce, 1930–1936, 1937–1944). By 1930, 47 of the existing 48 states and the District of Columbia were included in the national vital statistics system, in 1933 – Texas, in 1959 – Alaska, and in 1960 – Hawaii (Hetzel, 1997; Wingo et al., 2003).

Cancer...

Keywords

Thyroid Cancer Black Woman Black Male High Incidence Rate Black Female 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Armstrong B.K., Ray R.M., Thomas D.B., 1988. Endometrial cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol 17:263–269.CrossRefGoogle Scholar
  2. Axtell L.M., Asire A.J., Myers M.H., 1976. Cancer Patient Survival: Report Number 5. NIH Publ. 81–992. Bethesda: National Cancer Institute.Google Scholar
  3. Benshushan A., Paltiel O., Brzezinski A. et al., 2001. Ovulation induction and risk of endometrial cancer: a pilot study. Eur J Obstet Gynecol Reprod Biol 98:53–57.CrossRefGoogle Scholar
  4. Blot W.J., Fraumeni J.F., 1987. Trends in esophageal cancer mortality among US blacks and whites. Am J Public Health 77:296–298.CrossRefGoogle Scholar
  5. Boyle P., Severi G., Giles G.G. 2003. The epidemiology of prostate cancer. Urol Clin North Am 30:209–217.CrossRefGoogle Scholar
  6. Brinton L.A., Lacey J., Devesa S.S., 2002. Epidemiology of breast cancer. In: Donegan W.L., Spratt J.S. (Eds.) Cancer of the Breast. 5th edition. Orlando, FL: Saunders, pp. 111–132.Google Scholar
  7. Brown L.M., Devesa S.S., 2002. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 11:235–256.CrossRefGoogle Scholar
  8. Bufill J.A., 1990. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113:779–788.Google Scholar
  9. CDC, 2002. National Center for Chronic Disease Prevention and Health Promotion. Behavioral Risk Factor Surveillance System, Nationwide. 2002 Women’s Health Prevalence Data. At: www.cdc.gov/
  10. CDC, 2004. Cigarette smoking among adults – United States, 2002. MMWR 53:428–431.Google Scholar
  11. Centers for Disease Control and Prevention, 1960–1998. National Center for Health Statistics. Multiple cause of death public use data files. Hyattsville, MD: National Center for Heath Statistics.Google Scholar
  12. Chow W-H., Devesa S.S., 1992. Death certificate reporting of colon and rectal cancers [letter to the editors]. JAMA 267:3028.CrossRefGoogle Scholar
  13. Chow W-H., Devesa S.S., Warren J.L., Fraumeni J.F. Jr., 1999. Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631.CrossRefGoogle Scholar
  14. Collaborative Group on Hormonal Factors in Breast Cancer, 1997. Breast cancer and hormone replacement therapy: collaborative re-analysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350:1047–1059.CrossRefGoogle Scholar
  15. Cook L.S., Weiss N.S., Doherty J.A., Chen C., 2006. Endometrial cancer. In: Schottenfeld D., Fraumeni J.F. Jr. (Eds.) Cancer Epidemiology and Prevention. 3rd edition. Oxford: University Press.Google Scholar
  16. Correa P., Chen V.W., 1995. Endocrine gland cancer. Cancer 75:338–352.CrossRefGoogle Scholar
  17. Cutler S.J., Young J.L. (Eds.), 1975. Third National Cancer Survey: Incidence Data. National Cancer Institute Monograph 41. Washington, DC: U.S. Government Printing Office.Google Scholar
  18. Devesa S.S., Chow W-H., 1993. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 71:3819–3826.CrossRefGoogle Scholar
  19. Division of Cancer Prevention and Control., 1988. National Cancer Institute. 1987 Annual Cancer Statistics Review: including cancer trends 1950–1985. NIH Publication No. 88-2789.Google Scholar
  20. Dorn H.F., Cutler S.J., 1959. Morbidity from cancer in the United States: Parts I and II. Public Health Monograph 56-1-207. Bethesda: DHEW.Google Scholar
  21. Dornschneider G., Izbicki J.R., Wilker D.K. et al., 1990. The effects of sex steroids on colon carcinogenesis. Anticancer Drugs 1:15–21.CrossRefGoogle Scholar
  22. Edwards B.K., Howe H.L., Ries L.A. et al., 2002. Annual report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94:2766–2792.CrossRefGoogle Scholar
  23. Etzioni R., Legler J.M., Feuer E.J. et al., 1999. Cancer surveillance series: interpreting trends in prostate cancer – part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 91:1033–1039.CrossRefGoogle Scholar
  24. Federal Security Agency, 1945–1949. Public Health Service, National Office of Vital Statistics. Vital statistics of the United States. Part I. Washington: Government Printing Office.Google Scholar
  25. Feuer E.J., Merrill R.M., Hankey B.F., 1999. Cancer surveillance series: interpreting trends in prostate cancer – part II: cancer of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 91:1025–1032.CrossRefGoogle Scholar
  26. Fontham E.T.H., Correa P., 1989. Epidemiology of pancreatic cancer. Surg Clin N Am 69:551–567.Google Scholar
  27. Grady D., Ernster V.L., 1996. Endometrial cancer. In: Schottenfeld D., Fraumeni J.F. Jr. (Eds). Cancer Epidemiology and Prevention. New York: Oxford University Press.Google Scholar
  28. Harlan L.C., Abrams J., Warren J.L. et al., 2002. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol 20:1809–1817.CrossRefGoogle Scholar
  29. Harris R., Lohr K.N., 2002. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:917–929.Google Scholar
  30. Henderson B.E., Casagrande J.T., Pike M.C. et al., 1983. The epidemiology of endometrial cancer in young women. Br J Cancer 47:749–756.Google Scholar
  31. Hetzel A.M., 1997. U.S. Vital Statistics System, Major Activities and Developments, 1950–1995. Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics.Google Scholar
  32. Hollowell J.G., Staehling N.W., Flanders W.D., et al., 2002. Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499.CrossRefGoogle Scholar
  33. Howe H.L., Wingo P.A., Thun M.J., Ries L.A., Rosenberg H.M., Feigal E.G., Edwards B K., 2001. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl. Cancer Inst. (Bethesda) 93:824–842.Google Scholar
  34. Hsing A., Devesa S.S., 2001. Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev 23:3–13.Google Scholar
  35. Hsing A., Nomura A., Isaacs W. et al., 2001. Epidemiologic reviews: prostate cancer. Baltimore (MD): Oxford University Press, Vol. 23, No. 1..Google Scholar
  36. Hulka B.S., Stark A.T., 1995. Breast cancer: cause and prevention. Lancet 346:883–887.CrossRefGoogle Scholar
  37. Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). Available at www.mortality.org or www.humanmortality.de (data downloaded on January 2006).
  38. Koepsell T.D., Weiss N.S., Thompson D.J. et al., 1980. Prevalence of prior hysterectomy in the Seattle-Tacoma area. Am J Public Health 70:40–47.CrossRefGoogle Scholar
  39. Lacey J.V., Devesa S.S., Brinton L.A., 2002. Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39:82–88.CrossRefGoogle Scholar
  40. Lampe J.W., Fredstrom S.B., Slavin J.L. et al., 1993. Sex differences in colonic function: a randomized trial. Gut 34:531–536.CrossRefGoogle Scholar
  41. Levi F., La Vecchia C., Gulie C. et al., 1991. Oral contraceptives and the risk of endometrial cancer. Cancer Causes Control 2:99–103.CrossRefGoogle Scholar
  42. London W.T., McGlynn K.A., 2006. Liver cancer. In: Schottenfeld D., Fraumeni J.F. Jr. (Eds.) Cancer Epidemiology and Prevention 3rd edition. Oxford: Oxford University Press.Google Scholar
  43. Lyon J.L., Gardner J.W., 1977. The rising frequency of hysterectomy: its effect on uterine cancer rates. Am J Epidemiol 105:439–443.Google Scholar
  44. Manton K.G., Akushevich I., Kulminski A. 2008 Human mortality at extreme ages: data from the National Long Term Care Survey and Linked Medicare Records, Math Popul Stud 15:137–159.Google Scholar
  45. Mariotto A., Feuer E., Harlan L. et al., 2002. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975–1999. J Natl Cancer Inst 94:1626–1634.Google Scholar
  46. Mathew A., Devesa S.S., Fraumeni J.F. Jr., Chow W-H., 2002. Global increases in kidney cancer incidence 1973–1992. Eur J Cancer Prev 11:171–178.CrossRefGoogle Scholar
  47. McMichael A.J., Potter J.D., 1985. Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 75:185–191.Google Scholar
  48. Meng M.V., Grossfeld G.D., Sadetsky N. et al., 2002. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology 60(3 Suppl 1):7–11.CrossRefGoogle Scholar
  49. Miller B.A., Feuer E.J., Hankey B.F., 1993. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 43:27–41.CrossRefGoogle Scholar
  50. NBER, 2007 Multiple Cause-of-Death Mortality Data from the National Vital Statistics System of the National Center for Health Statistics, 1959–2004, www.nber.org/data/multicause.html, access in 2007.
  51. Oliver S.E., May M.T., Gunnell D., 2001. International trends in prostate-cancer mortality in the “PSA era”. Int J Cancer 92:893–898.CrossRefGoogle Scholar
  52. Parkin D.M., Whelan S.L., Ferlay J. et al., 2002. Cancer Incidence in Five Continents. volume 8. Lyon, France: International Agency for Research on Cancer.Google Scholar
  53. Parkin D.M., Whelan S.L., Ferlay J., Teppo L., Thomas D.B. (Eds.), 2003. Cancer Incidence in Five Continents volume 8. IARC Scientific Publ. No. 155 Lyon: IARC.Google Scholar
  54. Percy C., Stanek E. III, Gloeckler L., 1981. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 71:242–250.CrossRefGoogle Scholar
  55. Percy C.L., Ries L.A.G., Van Holten V.D., 1990. The accuracy of liver cancer as the underlying cause of death on death certificates. Public Health Rep 105:361–368.Google Scholar
  56. Pokras R., Hufnagel V.G., 1987. Hysterectomies in the United States. DHHS Publ. No. (PHS) 88–1753. Hyattsville, MD: National Center for Health Statistics.Google Scholar
  57. Potosky A.L., Kessler L., Gridley G., Brown C.C., Horm J.W., 1990. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst 82:1624–1628.CrossRefGoogle Scholar
  58. Potosky A.L., Miller B.A., Albertsen P.C., Kramer B.S., 1995. The role of increasing detection in the rising incidence of prostate cancer. JAMA 273:548–552.CrossRefGoogle Scholar
  59. Qiu D., Kaneko S., 2005. Comparison of esophageal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960–2000). Jpn J Clin Oncol 35:564–567.CrossRefGoogle Scholar
  60. Ries L.A.G., Devesa S.S., 2006. Cancer incidence, mortality and patient survival in the United States. In: Schottenfeld D., Fraumeni J.F. Jr. (Eds). Cancer Epidemiology and Prevention. 3rd edition. Oxford, University Press, pp. 139–173.Google Scholar
  61. Ries L.A.G., Eisner M.P., Kosary C.L. et al., 2002. SEER Cancer Statistics Review, 1973–1999. Bethesda, MD: National Cancer Institute.Google Scholar
  62. Ries L.A.G., Eisner M.P., Kosary C.L. (Eds.) et al., 2004. SEER Cancer Statistics Review, 1975–2001. Bethesda, MD: National Cancer Institute. At: seer.cancer.gov/csr/1975_2001/
  63. Ron E., Schneider A.B., 2006. Thyroid cancer. In: Schottenfeld D., Fraumeni J.F. Jr. (Eds.) Cancer Epidemiology and Prevention. 3rd edition. Oxford: Oxford University Press.Google Scholar
  64. Rowland J., Mariotto A., Aziz N. et al., 2004. Cancer Survivorship – United States, 1971–2001. MMWR 53(24):526–529.Google Scholar
  65. Shaheen N.J., Hansen R.A., Morgan D.R. et al., 2006. The burden of gastrointestinal and liver diseases. Am J Gastroenterol 101:2128–2138.CrossRefGoogle Scholar
  66. Silverberg S.G., Makowski E.L., Roche W.D., 1977. Endometrial carcinoma in women under 40 years of age: comparison of cases in oral contraceptive users and non-users. Cancer 39:592–598.CrossRefGoogle Scholar
  67. Silverman D.T., Hoover R.N., Brown L.M. et al., 2003. Why do black Americans have a higher risk of pancreatic cancer than white Americans? Epidemiology 14:45–54.CrossRefGoogle Scholar
  68. Slattery M.L., Potter J.D., Curtin K. et al., 2001. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 61:126–130.Google Scholar
  69. Stanford J.L., Brinton L.A., Berman M.L. et al., 1993. Oral contraceptive and endometrial cancer: do other risk factors modify the association? Int J Cancer 54:243–248.CrossRefGoogle Scholar
  70. The Centers for Disease Control, Cancer and Steroid Hormone Study, 1983. Oral contraceptive use and the risk of endometrial cancer. JAMA 249:1600–1604.CrossRefGoogle Scholar
  71. The Centers for Disease Control, Cancer and Steroid Hormone Study, 1987. Combination oral contraceptive use and the risk of endometrial cancer. JAMA 257:796–800.CrossRefGoogle Scholar
  72. Troisi R., Freedman A., Devesa S., 1999. Incidence of colorectal carcinoma in the United States: an update of trends by gender, race, age, subsite, and stage, 1975–1994. Cancer 85:1670–1676.CrossRefGoogle Scholar
  73. U.S Public Health Service, 1964. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. U.S. Department of Health, Education and Welfare, Public Health Service Publication No. 1103. U.S. Government Printing Office: 1964.Google Scholar
  74. U.S. Department of Commerce, 1930–1936. Bureau of the Census. Mortality Statistics. Washington, DC: U.S Government Printing Office.Google Scholar
  75. U.S. Department of Commerce, 1937–1944. Bureau of the Census. Vital Statistics of the United States. Part I. Washington, DC: Government Printing Office.Google Scholar
  76. U.S. Department of Health and Human Services, 1981. Hysterectomy in women aged 15–44. United States, 1970–1978. MMWR 30:173–176.Google Scholar
  77. U.S. Department of Health and Human Services, 2000. Tracking Healthy People 2010. Washington, DC: U.S. Government Printing Office.Google Scholar
  78. U.S. Department of Health, Education and Welfare, 1950–1959. Public Health Service, National Office of Vital Statistics. Vital Statistics of the United States. Volume 2. Washington, DC: Government Printing Office.Google Scholar
  79. U.S. Vital Statistics System, 1950. History and Organization of the Vital Statistics System. Volume 1. Hyattsville, MD: U.S. Vital Statistics System 1950:1–19.Google Scholar
  80. Vainio H., Bianchini F., 2002. IARC Handbook of Cancer Prevention. Volume 6: Weight Control and Physical Activity. Lyon, France: IARC Press.Google Scholar
  81. Weiderpass E., Adami H.O., Baron J.A. et al., 1999. Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Cause Control 10:277–284.CrossRefGoogle Scholar
  82. Weir H.K., Thun M.J., Hankey B.F. et al., 2003. Annual report to the Nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95(17):1276–1299.Google Scholar
  83. Welch H.G., Schwartz L.M., Woloshin S., 2000. Are increasing 5-year survival rates evidence of success against cancer? JAMA 283(22):2975–2978.CrossRefGoogle Scholar
  84. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, 1991. Depot medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. Int J Cancer 49:186–190.Google Scholar
  85. Wingo P.A., Ries L.A., Rosenberg H.M. et al., 1998. Cancer incidence and mortality, 1973–1995: a report card for the U.S. Cancer 82:1197–1207.CrossRefGoogle Scholar
  86. Wingo P.A., Cardinez C.J., Landis S.H. et al., 2003. Long-term trends in cancer mortality in the United States, 1030–1998. Cancer Supplement 97(12):3133–3275.Google Scholar
  87. Wu X.C., Chen V.W., Steele B. et al., 2001. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer 92:2547–2554.CrossRefGoogle Scholar
  88. Yoon Y-H., Yi H-Y., 2006. Liver cirrhosis mortality in the United States, 1970–2003. At NIAAA (National Institute on Alcohol Abuse and Alcoholism) site: pubs.niaaa.nih.gov/publications/surveillance75/images/fig8.gif

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • K.G. Manton
    • 1
  • Igor Akushevich
    • 1
  • Julia Kravchenko
    • 1
  1. 1.Duke UniversityDurhamUSA

Personalised recommendations